Search Results - "Aftab, B.T."

CD19 chimeric antigen receptor (CAR) engineered epstein-barr virus (EBV) specific T cells – an off-the-shelf, allogeneic CAR T-cell immunotherapy platform by Shen, R.R, Pham, C.D, Wu, M, Munson, D.J, Aftab, B.T

“…Background & AimChimeric antigen receptor (CAR) T cells have demonstrated potent antitumor efficacy in treating a range of B-cell malignancies, yet technical…”
Get full text

Immunotherapy: EVALUATION OF NON-GENE EDITED ALLOGENEIC “OFF-THE-SHELF” Vδ1 γδ CAR T CELLS TARGETING CD20 FOR B CELL MALIGNANCIES by Azameera, A., Lamture, G., Au, M., Barca, T., Teague, A., Wong, J., Gundurao, S.R., Doan, A., Herrman, M., Panuganti, S., Bhat, A., Aftab, B.T., Nishimoto, K.

Get full text

Developing adoptive T cell therapy for Polyomavirus-associated diseases using HLA-defined peptide platform by Thomas, G. Ambalathingal, FRancis, R.S., Corvino, D., Srihari, S., Nellar, M., Aftab, B.T., Smith, C., Khanna, R.

“…Polyomavirus infection is a growing threat among immunocompromised patients. Reconstitution of T cell immunity has been shown to control the infection. Hence,…”
Get full text

Gene expression profiling and TCR diversity of ATA188, a Pre-manufactured, Allogeneic Epstein-Barr Virus-targeted T-cell Immunotherapy for Patients with Multiple Sclerosis by Foubert, P., Srihari, S., Le Textier, L., Shen, R.R., Forozan, F., Smith, C., Khanna, R., Aftab, B.T.

“…There is increasing evidence that infection with the Epstein-Barr virus (EBV) plays a role in the development and pathogenesis of multiple sclerosis (MS). We…”
Get full text

Comprehensive activation profiling of tabelecleucel, an off-the-shelf, allogeneic EBV-specific T-cell immunotherapy by Ruiz, F., Jehng, T., Spindler, T., Munson, D.J., Karlen, J., Thota, V., Wang, A., Chuan, J., Yedwabnick, M., Dubovksy, J., Aftab, B.T.

Get full text

Epstein-Barr virus-specific cytotoxic T lymphocyte precursors (EBV-CTLp) after tabelecleucel correlates with response & survival in rituximab relapsing or refractory EBV posttransplant lymphoproliferative disease (PTLD) by Prockop, S., Shen, R.R., Guzman-Becerra, N., Sun, Y., Forozan, F., Doubrovina, E., O'Reilly, R.J., Li, X., Hiremath, M., Gamelin, L., Navarro, W., Aftab, B.T.

“…EBV PTLD is often a fatal disease. Tabelecleucel is an investigational off-theshelf, allogeneic T-cell immunotherapy specific for EBV antigens. Functional in…”
Get full text

Comprehensive profiling of ATA188, an off-the-shelf, allogeneic epstein-barr virus-specific T-cell immunotherapy for progressive multiple sclerosis by Moreno, M., Srihari, S., Ruiz, F., Ambalathingal Thomas, G., Le Texier, L., Panikkar, A., Raju, J., Rehan, S., Beagley, L., Solomon, M., Smith, C., Dubovsky, J., Khanna, R., Aftab, B.T.

Get full text